State governments are reevaluating their role in the assessment of med
ical technologies. This paper outlines a range of state technology ass
essment activities, highlighting programs in Minnesota, Oregon, and Wa
shington, and discusses the issues associated with state government in
volvement. Clinically oriented activities on the state level can infor
m efforts to contain costs, educate consumers and providers, and facil
itate local consensus on the appropriate uses of new and existing tech
nologies. Although current programs are still in their infancy and the
ir viability remains uncertain, the importance of technology assessmen
t is growing as technology continues to fuel increasing costs. The fut
ure of state-level technology assessment may lie in collaborative vent
ures with other states, the federal government, or private industry.